Endpoints News

Endpoints News

Meet Endpoints' new deputy editors		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T Wed Th F

18 March, 2026

AI-driven drug discovery is already reshaping pipelines. But algorithms alone won’t get a drug to the clinic. Join us for a free virtual program — then continue the conversation at an in-person only fireside chat and happy hour in Boston. Reserve your spot.

presented by

Parexel Biotech

5 ways to secure biotech funding in 2026

spotlight

Karen Weintraub and Kevin Miller to join Endpoints News as editors

news

With its first AI model release, Xaira tests scaling laws in virtual cells

Drugmakers consider licensing deal tweaks to soften MFN impact

CMS innovation center to expand staff with focus on drug pricing, director says

Mar 24

11:30 am ET

From structure to selectivity: Federated AI for collaborative binding affinity prediction

sponsored by Rhino Federated Computing

The patent cliff is closing in and the dealmaking math has changed fast. Bidding wars, thawing capital markets and a new antitrust environment are all in play — join Drew Armstrong and FT Live for a breakdown on March 18. Register to watch.

in case you missed it

1.

Roche, Nvidia will build pharma's largest 'AI factory,' eclipsing Lilly's supercomputer

2.

Bicycle to cut 30% of staff after cancer drug's regulatory setback

3.

Aldeyra dry eye drug gets third rejection from FDA, triggering stock slide

4.

Rhythm’s Imcivree fails Phase 3 for rare form of obesity as PDUFA date nears for larger indication

5.

News Briefing

Pfizer's next-gen breast cancer data; Bristol Myers' PRMT5 candidate

6.

J&J pulls out of JLABS New York location as it shrinks incubator footprint

7.

Exclusive: China mRNA therapy startup Innorna to test gout treatment in US

8.

New renal disease biotech R1 Therapeutics nabs $77.5M for Phase 2b

9.

FTC monitoring how drug companies react to patent cliff, official says

10.

Senator finds GSK profited by pulling asthma inhaler critical for kids

Reynald Castaneda

.

Endpoints will be adding Karen Weintraub and Kevin Miller to our editorial team! Read more about them here.

.

Reynald Castaneda

Deputy Editor, Endpoints News